Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Debt to Equity (2020 - 2021)

Pharma-Bio Serv's Debt to Equity history spans 2 years, with the latest figure at $0.09 for Q2 2021.

  • For Q2 2021, Debt to Equity rose 1.17% year-over-year to $0.09; the TTM value through Apr 2021 reached $0.09, up 1.17%, while the annual FY2020 figure was $0.09, N/A changed from the prior year.
  • Debt to Equity reached $0.09 in Q2 2021 per PBSV's latest filing, down from $0.09 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.09 in Q1 2021 to a low of $0.09 in Q4 2020.